To survive starvation conditions, eukaryotes have developed an evolutionarily conserved process, termed autophagy, by which the vacuole/lysosome mediates the turnover and recycling of non-essential intracellular material for re-use in critical biosynthetic reactions. Morphological and biochemical studies in Saccharomyces cerevisiae have elucidated the basic steps and mechanisms of the autophagy pathway. Although it is a degradative process, autophagy shows substantial overlap with the biosynthetic cytoplasm to vacuole targeting (Cvt) pathway that delivers resident hydrolases to the vacuole. Recent molecular genetics analyses of mutants defective in autophagy and the Cvt pathway, apg, aut and cvt, have begun to identify the protein machinery and provide a molecular resolution of the sequestration and import mechanism that are characteristic of these pathways. In this study, we have identified a novel protein, termed Apg2, required for both the Cvt and autophagy pathways as well as the specific degradation of peroxisomes. Apg2 is required for the formation and/or completion of cytosolic sequestering vesicles that are required for vacuolar import through both the Cvt pathway and autophagy.
Introduction (12) . The Tor signaling cascade also affects the phosphorylation state of Apg13 and its affinity for the Apg1 kinase (13) . Recently, Cvt9 and Apg17 were characterized as additional proteins that associate with the Apg1 kinase (13, 14) . Interestingly, Cvt9 is specific for the Cvt pathway and is also needed for pexophagy while Apg17 is specific for autophagy. These findings suggest that a potential protein complex including the Apg1 kinase and various regulatory proteins may determine which of these pathways operates within the cell.
One of the most distinctive features of the Apg/Cvt pathways is the formation of sequestering vesicles that engulf cytoplasm. A major difference between autophagy and the Cvt pathway is that autophagosomes are substantially larger than the Cvt vesicles that form under nutrient-rich conditions. Aut7 is the first identified component that localizes to both Cvt vesicles and autophagosomes. The level of Aut7 is up-regulated under starvation conditions, suggesting that it is a limiting component that is required for Cvt vesicle formation as well as autophagosome expansion (15, 16) . The formation and completion of the Cvt vesicle/autophagosome also requires a novel protein conjugation system consisting of Apg5, Apg7, Apg10, Apg12 and Apg16 (17) (18) (19) (20) . Recent findings suggest that Aut7 membrane association is dependent on the autophagy (Apg) conjugation system as well as a novel membrane lipidation process involving the Aut1 protein (21, 22) . Finally, Apg9 is the only characterized integral membrane protein required for the vesicle formation/completion step for both the Cvt and autophagy pathways. It is localized at a perivacuolar punctate structure that appears to be distinct from typical plasma membrane and endomembrane marker proteins.
Cells were grown in TYE to A 600 = 1.0 and then fusion protein expression was induced for 3 h by adding IPTG (final concentration of 0.5 mM). Cells were lysed by sonication to obtain the crude cell lysate followed by column purification procedures as described by the suppliers of the vector fusion systems. The GST fusion system was from Amersham Pharmacia Biotech and the pMAL protein fusion and purification system was from New England Biolabs, Inc. (Beverly, MA).
Antiserum was generated in a New Zealand white rabbit using standard procedures (24) .
Antisera against API (25) , Apg9 (23) , and Fox3 (11) were prepared as described previously.
Monoclonal antibodies to alkaline phosphatase (ALP) and Dpm1 were from Molecular Probes (Eugene, OR). Antiserum against α-1,3-mannosyltransferase (Mnn1), Pep12 and phosphoglycerate kinase (PGK) were generously provided by Dr. Todd Graham (Vanderbilt University, Nashville, TN), Dr. Scott Emr (University of California at San Diego, La Jolla, CA) and Dr. Jeremy Thorner (University of California at Berkeley, Berkeley, CA), respectively.
Disruption and Cloning of APG2The apg2∆ strains were made by replacing the APG2
ORF with the HIS5 gene from S. pombe. The HIS5 gene was PCR amplified using the plasmid pME3 as template. The 5' and 3' ends of the knockout cassette contains 41 bp of flanking region beginning 8 bases after the start codon of the APG2 ORF, and 66 bp after the stop codon, respectively. Plasmid pYCG_YNL242w containing the APG2 gene in pRS416 was digested with SpeI and KpnI and a 5.7 Kb fragment cloned into the SpeI and KpnI sites of pRS426 to generate the multi-copy plasmid pAPG2(426).
pRS416-ProtA-APG9, respectively. The corresponding fragments were cloned into the BamHI and SalI sites of pRS425 to generate pRS425-ProtA and pRS425-ProtA-APG9. The plasmid pRS416-ProtA was a gift from Dr. Scott Emr (University of California at San Diego, La Jolla, CA). The construction of pRS416-ProtA-APG9 will be described elsewhere (J. Kim, W.-P.
Huang and D.J. Klionsky, manuscript in preparation).
To fuse GFP to the NH 2 terminus of Apg2, the APG2 ORF was amplified by PCR using pYCG_YNL242w as the template. The 5' and 3' oligonucleotides used for the PCR amplification were 5'-TTGATTTCGACCCGGGGGCATTTTGGTTACCTCAAAATATACAAAAGCG-3' and 5'-ATATCAAAAATGTCGGTACCAATTTTTACGAATCAGTCCGATTGGACTT-3', respectively. The 5' oligonucleotide contains an XmaI site that is in the same reading frame as the end of the GFP ORF of pCuGFP(414), a plasmid in which GFP expression is under the control of the CUP1 copper-inducible promoter (22) . The 3' oligonucleotide contains a KpnI site. The APG2 PCR product was subcloned into pCuGFP(414) by an XmaI-KpnI digest, resulting in the pCuGFPAPG2(414) plasmid.
Cell Viability Under Nitrogen Starvation ConditionsTo examine the survival of various
yeast strains under nitrogen starvation conditions, cells were grown to an A 600 = 1.0 in SMD medium, washed once in SD-N, and then resuspended in SD-N to an A 600 = 1.0. At the indicated times, aliquots were removed, serially diluted and plated onto YPD plates in triplicate. After 2-3 d incubation, colonies were counted on plates.
immunoprecipitation as described previously (9) . Subcellular FractionationWild-type cells (SEY6210) were spheroplasted at an A 600 = 1.0 before osmotic lysis in PS200 buffer containing 0 or 5 mM MgCl 2 . The total cell lysates were then subjected to centrifugation at 13,000 × g for 10 min at 4°C, resulting in soluble (S13) and pelletable (P13) fractions. The S13 fraction was further centrifuged at 100,000 × g in a Beckman
Coulter, Inc. (Fullerton, CA) Optima™ MAX-E ultracentrifuge using a TLA 100.4 rotor for 30 min at 4°C to generate the corresponding S100 and P100 fractions. The resulting fractions were TCA precipitated and washed twice with acetone followed by immunoblot with anti-Apg2 antiserum. To further examine the biochemical nature of the Apg2p pelletable fractions, spheroplasts of wild type cells were osmotically lysed in PS200 lysis buffer containing 5 mM MgCl 2 . The cell lysate was aliquoted and then centrifuged at 100,000 × g for 30 min. The total pellet fraction was collected and resuspended in one of the following buffers: 1 M KCl, 0.1 M Na 2 CO 3 (pH 10.5), 3 M Urea, 1% Triton X-100. After incubation at room temperature for 10 min, all samples were separated into supernatant (S) and pellet (P) fractions by centrifugation at 100,000 × g for 30 min. The samples were analyzed by western blot as described previously (9) .
OptiPrep Density Gradient Wild type cells were grown to mid-log phase and converted into spheroplasts before being subjected to osmotic lysis in PS200 buffer containing 1 mM EDTA, 1 mM MgCl 2 , and a protease inhibitor cocktail (Complete  TM EDTA-free protease inhibitor tablets, 1mM PMSF, 1µg/ml leupeptin, and 1µg/ml pepstatinA). After a pre-clear centrifugation step at 800 × g for 5 min to remove the cell debris, the crude lysate (20 A 600 units of cells) was centrifuged at 100,000 × g for 20 min at 4°C. The resulting total membrane fraction was resuspended in lysis buffer and layered on top of a density gradient consisting of 0-66% OptiPrep in PS200 containing 1 mM EDTA, 1 mM MgCl 2 and 1 mM DTT, and a protease inhibitor cocktail. The gradients were subjected to centrifugation at 100,000 × g for 16 h at 4°C in a TLS 55 rotor. Samples were collected from the top of the gradients into 14 fractions. The fractions were then resolved by SDS-polyacrylamide gel electrophoresis and examined by immunoblot using antiserum or antibodies against Apg2, Dpm1, Mnn1, Pep12, ALP, and Apg9.
Protein A Pull-Down-The multi-copy APG2 plasmid, pAPG2(426), was co-transformed into SEY6210 wild type cells with pRS425-ProtA or pRS425-ProtA-APG9. Spheroplasts prepared from transformants were grown to mid-log phase and lysed by Dounce homogenization at a cell density of 30 A 600 /ml in PBS lysis buffer with or without 0.5% NP-40 (1x PBS, 200 mM sorbitol, 5 mM MgCl 2 , +/-0.5% NP-40 and protease inhibitors). Cell lysates (1 ml) were incubated with 20 µl of Dynabeads M-500 Subcellular cross-linked to human IgG for 2 h at 4°C.
The beads were then washed in PBS lysis buffer 4 times and eluted with SDS-polyacrylamide gel electrophoresis sample buffer. Apg2 was detected by immunoblot.
Pexophagy Thiolase AssayThe assay was carried out essentially as described previously (11) . In brief, cells were grown in YPD to the exponential stage and then shifted to SGd for 12 h at 30°C. A 10× solution of YP was added to a final concentration of 1× and the culture incubated 4 h at 30°C. Cells were then shifted to YTO for 19 h to induce peroxisomes. Cells were harvested and washed once in 1× YNB (0.67% YNB) and SD-N, respectively. After washing, cells were resuspended in SD-N to an A 600 = 1.0. At the indicated times, aliquots were removed, TCA precipitated and then subjected to immunoblot with anti-Fox3 antiserum.
Fluorescence Microscopy-Induction of peroxisomes in cells expressing GFPSKL was done as described for the pexophagy thiolase assay. Following induction, cells were shifted to SD-N. At 0, 12 and 26 h following incubation in SD-N medium, aliquots were removed and examined by fluorescence microscopy. To examine GFPApg2 localization, cells were grown to midlog phase and viewed directly or shifted to SD-N medium for 4 h prior to examination.
Microscopy was performed on a Nikon E-800 fluorescent microscope (Mager Scientific Inc., Dexter, MI). Images were captured by an ORCA II CCD camera (Hamamatsu Corp., Bridgewater, NJ) using Openlab software (Improvision, Inc., Lexington, MA).
To examine induction and stability of Apg2 and GFPApg2, the apg2∆ (CWY1) and apg9∆ (JKY007) strains transformed with a plasmid expressing GFPApg2, and non-transformed apg9∆
and wild type (SEY6210) strains were grown in SMD or shifted to SD-N for 4 h. Protein extracts were prepared and resolved by SDS-polyacrylamide gel electrophoresis. GFPApg2 and Apg2 were detected by western blot using antiserum against Apg2. (Fig. 1A) .
RESULTS

Apg2 is a Shared Component of the Autophagy and Cvt Pathways
To determine if the YNL242w gene complemented any of the previously isolated mutant strains that are defective in prAPI import, we transformed the cvt and apg mutants with a plasmid encoding this gene. One of the mutants, apg2, displayed complementation of the prAPI accumulation phenotype when transformed with this plasmid (data not shown). Both the single copy and multi-copy plasmids of APG2 rescued the prAPI processing defect in the apg2 mutant, as well as in the apg2∆ strain (Fig. 1A) . The apg2 mutant was originally isolated from a morphological screen for cells that failed to accumulate autophagic bodies under starvation conditions in the presence of PMSF (28) . A diploid strain constructed by mating the apg2 mutant with ynl242w∆ was defective for prAPI import (data not shown) further suggesting that APG2 is allelic with YNL242w. The YNL242w gene was first identified as part of the systematic disruption of yeast ORFs (29) . The ynl242w homozygous null strain was found to be defective in sporulation and the gene was named SPO72. Many mutants defective in vacuolar function are also defective in sporulation. Because our studies suggest a more specific role for the YNL242w gene product in transport of proteins from the cytoplasm to the vacuole, we will refer to this ORF as APG2 hereafter in this study.
Mutants that are defective only in the Cvt pathway or that are not needed for the induction or nucleation steps of autophagy show substantial maturation of prAPI following a shift to starvation conditions. For example, prAPI is almost completely processed to the mature form in the vac8∆ strain upon induction of autophagy (30) . In contrast, mutants that are tightly blocked in autophagosome formation do not show a reversal of the prAPI phenotype when shifted to starvation media. To determine whether the apg2∆ strain was defective in autophagosome formation, we grew apg2∆ cells in rich medium, shifted the cells to SD-N and examined the prAPI phenotype. The defect in prAPI processing in the apg2∆ strain did not reverse when cells were shifted from rich medium to starvation conditions (data not shown), suggesting that autophagy was blocked in this strain. Autophagy provides the essential machinery that prolongs cell viability in nitrogen deprivation conditions. As a further assessment of the autophagic capacity of the apg2∆ strain, we examined the viability of apg2∆ cells under starvation conditions. Both the wild type and apg2∆ strains transformed with a CEN APG2 plasmid showed a high level of viability even after 8 d in SD-N medium (Fig. 1B) . In contrast, the apg2∆ strain exhibited a dramatic decrease in cell viability within 5 d in SD-N indicating a severe autophagy defect. From these studies, we conclude that Apg2 is a novel protein required for both the biosynthetic Cvt pathway and the degradative autophagy pathway. The defect in autophagy seen in the apg2∆ strain explains the previously observed sporulation defect of the ynl242w mutant (29) .
The inability to reverse the prAPI accumulation phenotype in starvation conditions and the decrease in viability in nitrogen-depleted medium suggested that Apg2 was required for the induction and/or formation of autophagosomes. To gain further insight into the stage of action of Apg2, we examined the state of prAPI during import through the Cvt pathway. apg2∆ cells were harvested at mid-log phase and subjected to spheroplasting followed by osmotic lysis. The crude cell lysates were separated into a low-speed supernatant fraction (S13), and a pellet fraction (P13) containing prAPI. The P13 fraction was then treated with exogenous protease in the absence or presence of detergent. As a control, we also analyzed the phenotype of prAPI accumulated in the ypt7∆ and apg7∆ strains in the same experiment. Apg7 is an E1-like (ubiquitin activating) ATPase and functions in the initiation step of the conjugation machinery that is required for both the Cvt and autophagy pathways (26) . The apg7∆ strain accumulated membrane associated, but protease-sensitive precursor API, and thus can be characterized as a protein required for the completion stage of Cvt vesicle and autophagosome formation ( Fig. 2A; 26). Ypt7 is a Rab GTPase that plays a role in yeast endosomal transport. Because it is also required for the fusion step for both the Cvt and autophagy pathways, the ypt7∆ strain accumulates protease-resistant prAPI inside the completed cytosolic vesicle ( Fig. 2A; 26 ).
Precursor API was found in a pelletable fraction in the apg2∆ strain similar to the result seen in the apg7∆ and ypt7∆ strains. As in the apg7∆ strain, prAPI in the apg2∆ strain was mostly sensitive to exogenous protease. These results suggest that loss of Apg2 causes a defect in the sequestration of prAPI into completed Cvt vesicles.
prAPI transport defect, we checked the magnesium-dependent pelleting of prAPI in the apg2∆ strain. Yeast spheroplasts were lysed in the presence of various concentrations of MgCl 2 , followed by centrifugation as described in " Experimental Procedures." Precursor API in the apg2∆ strain exhibited a magnesium-dependent association with a pelletable fraction similar to that in the apg7∆ strain. This result suggests that Apg2 is not needed for the membrane binding of the Cvt complex (data not shown).
We extended the analysis of membrane binding by examining flotation of the proteasesensitive prAPI. In this analysis, spheroplasts are osmotically lysed and the cell lysate is resolved on a Ficoll-400 step gradient. Membrane-associated proteins float to the top layer of the gradient (F), whereas soluble proteins remain in the non-float (NF) fraction, and proteins associated with a large complex are pelleted (P2). The apg2∆ cells were spheroplasted at midlog phase and then subjected to centrifugation at 13,000 × g to collect a pellet fraction (P). This prAPI-containing pellet fraction was then subjected to the flotation analysis. In the absence of detergent, the majority of prAPI was located in both the F and P2 fractions (Fig. 2B) . However, the prAPI present in the float fraction was shifted to the P2 fraction in the presence of detergent.
These data suggest that a population of membrane-associated prAPI accumulated in the apg2∆ cells, further indicating that Apg2 is not necessary for binding of the Cvt complex to its target membrane. Taken together, the protease protection and membrane binding experiments suggest that Apg2 plays a role in formation/completion of the sequestering vesicles.
Apg2 is a Membrane-Associated, Peripheral ProteinIn order to study the biosynthesis of Apg2, we generated polyclonal antiserum against the protein as described in "Experimental
Procedures." Protein extracts were prepared and examined by immunoblot using the anti-Apg2 antiserum (Fig. 3) . In the wild type strain, a single predominant band of approximately 180 kD was detected, consistent with the expected size of Apg2 based on the deduced amino acid sequence. This band was not detected in the apg2 and apg2∆ strains. In addition, the crude cell lysate derived from apg2∆ cells expressing a multi-copy APG2 plasmid showed a greatly increased level of this protein. These results suggest that the serum was specific for Apg2. (15) . In contrast, the steady-state protein level of Apg2 was not obviously changed upon shift to SD-N (Fig. 5C ).
To investigate the site of action for Apg2, we examined the protein by subcellular fractionation. The wild type strain SEY6210 was grown to mid-log phase, and subjected to spheroplasting followed by osmotic lysis in PS200 buffer in the absence or presence of 5 mM MgCl 2 . The crude cell lysates were then centrifuged at 13,000 × g to generate low-speed supernatant (S13) and pellet (P13) fractions. The S13 fractions were then separated into highspeed supernatant (S100) and pellet (P100) fractions by 100,000 × g centrifugation. The distribution of the abundant cytosolic protein, phosphoglycerate kinase (PGK), served as a marker to confirm faithful separation of membrane and soluble proteins. As expected, PGK was recovered in the supernatant fractions in the absence or presence of MgCl 2 (Fig. 4B) . When we examined the pelletability of Apg2 by lysing spheroplasts in buffers containing 0 or 5 mM MgCl 2 , we found that the association of Apg2 with the pellet fraction was destabilized in the absence of MgCl 2 . About 40% of the total Apg2 was still detected in the P100 fraction, however, even when cells were lysed in buffers lacking MgCl 2 (Fig. 4B ). These data suggest that Apg2 localizes to both a soluble and pelletable fraction in a salt-dependent manner.
The predicted amino acid sequence of Apg2 has no apparent transmembrane domains or site of lipid modification. Because many of the Apg and Cvt proteins are associated with a membrane fraction, we decided to examine the pelletable nature of Apg2 in greater detail. To gain further insight into the nature of its interaction with the membrane, we biochemically examined the stability of membrane binding. Spheroplasts from wild type cells were lysed and centrifuged at 100,000 × g as described in "Experimental Procedures" to collect the total membrane pellet fraction. As a control, we analyzed the vacuolar membrane marker alkaline phosphatase (ALP). As expected, detergent efficiently solubilized ALP whereas salt, pH, and urea treatments retained the protein in the pellet fractions (Fig. 4C) . In contrast, the pelletable fraction of Apg2 was stripped from the membrane by 1 M KCl and 0.1 M Na 2 CO 3 (pH 10.5), and was partially removed with 3 M urea (Fig. 4C) . However, the majority of Apg2 remained in the pellet fraction fol1owing treatment with 1% Triton X-100, suggesting that Apg2 may interact with a detergent-resistant protein complex. Taken together, the data indicate that Apg2 behaves like a peripheral membrane protein.
Apg2 Localizes to the Apg9 Compartment-To investigate the subcellular localization of
Apg2 in vivo, we constructed an NH 2 -terminal fusion of GFP to Apg2 under control of the regulable CUP1 promoter. GFPApg2 expressed from a centromeric plasmid without copper induction showed partial complementation of the prAPI processing defect of the apg2∆ strain in SMD medium, but almost complete complementation when cells were shifted to SD-N (data not shown). When expressed in apg2∆ cells, GFPApg2 displayed both a cytosolic and punctate staining pattern (Fig. 5A) . The cytosolic staining pattern of the GFPApg2 fusion protein became more pronounced when GFPApg2 was expressed from a multi-copy plasmid or when synthesis from the CUP1 promoter was induced with copper (data not shown). These data suggest that overexpressed Apg2GFP saturated its membrane binding resulting in an increased cytosolic pool of the protein. The punctate pattern of GFPApg2 was localized in proximity to the vacuole (Fig. 5A) . Furthermore, the punctate staining was enhanced when cells were shifted to SD-N medium. This increase in signal intensity under starvation conditions is reminiscent of that seen for the Apg7GFP fusion protein (26) . To determine whether the increased intensity of the GFPApg2 dot seen in SD-N medium was due to induction of the protein, we examined the level of the protein in extracts prepared from cells grown in either SMD or SD-N medium. The
Apg2 and GFPApg2 steady state levels remained relatively constant under both rich and starvation conditions although there was a slight increase seen in SD-N (Fig 5C) . Because Apg2 and GFPApg2 are not induced substantially under starvation conditions, the increased intensity of the punctate dot probably reflects a higher level of recruitment of Apg2 to this perivacuolar structure when autophagy is induced.
Apg9 is an integral membrane protein we decided to examine whether it was needed for correct localization of Apg2. Accordingly, we examined GFPApg2 in the apg9∆ strain. We found that GFPApg2 displayed a primarily cytosolic localization in the apg9∆ strain in nutrient-rich conditions, suggesting that efficient Apg2 localization is dependent on the Apg9 protein (Fig.   5B ). Furthermore, shifting cells expressing GFPApg2 to SD-N medium did not facilitate its perivacuolar, punctate localization in the apg9∆ background (data not shown). In contrast, localization of Apg9GFP did not change in the apg2∆ strain (data not shown) suggesting that Apg9 localization is independent of Apg2. To verify that the loss of punctate signal in the apg9∆ strain was not due to degradation of the GFPApg2 protein, we examined the stability of Apg2
and GFPApg2 in wild type and apg9∆ cells under both rich medium and starvation conditions.
Both proteins were stable in the apg9∆ strain under either condition (Fig. 5C ). These data suggest that the predominantly cytosolic staining of GFPApg2 in the apg9∆ strain reflects detachment of GFPApg2 from the punctate dot structure and transfer to the cytosol, rather than degradation of the protein.
The GFP analysis suggested that Apg2 was localized to the same membrane compartment as Apg9. To extend our analysis of Apg2 localization, we resolved the Apg2 compartment by a density gradient analysis. Spheroplasts from wild type cells transformed with a 2µ APG9 plasmid were osmotically lysed and separated into supernatant and total membrane fractions by centrifugation at 100,000 × g. The membrane pellet was then resuspended and resolved on a linear 0-66% OptiPrep gradient. After centrifugation at 100,000 × g for 16 h, 14 fractions were collected from the top to the bottom and analyzed by immunoblot. The distribution of Apg2 was detected at fractions 6 through 9 with the peak concentration of Apg2 detected in fraction 8, while the vacuole membrane marker ALP localized at fractions 1 and 2 (Fig. 6A) . We also examined the endomembrane markers Dpm1 (ER), Mnn1 (Golgi), and Pep12 (endosome).
These proteins displayed fractionation patterns that were distinct from Apg2 (Fig. 6A) . The unique density gradient profile of Apg2 was reminiscent of the fractionation pattern observed for Apg9. Apg9 was also characterized as a protein that localized to a membrane compartment that did not co-fractionate with known endomembrane markers (23) . We compared the distribution of Apg2 and Apg9 on the OptiPrep gradients and found that they co-localized to the same peak fractions, suggesting residence in the same membrane compartment (Fig. 6B) .
The Apg9-dependent localization of Apg2 suggested that Apg2 and Apg9 might interact. To determine whether Apg2 associates with Apg9, we carried out a protein pull-down assay. Protein A was fused to the NH 2 terminus of Apg9. The protein A-Apg9 fusion protein rescued the prAPI transport defect of an apg9∆ strain, indicating that it was functional (Fig. 7A ). For the pull-down assay, spheroplasts expressing protein A-Apg9 or protein A alone were lysed, and the protein A constructs was recovered by incubating with Dynabeads coupled to IgG in the absence or presence of detergent. Interacting proteins were detected by western blot. The Apg2 protein was recovered along with protein A-Apg9 whether or not detergent was present, although the recovery was approximately 5-fold higher in the absence of detergent (Fig. 7B) . Apg2 was not recovered from cells expressing the protein A vector alone, indicating that the interaction was specific to Apg9 and not the protein A domain. These results further suggest that Apg2 is localized to the Apg9 compartment and that the two proteins interact directly or indirectly. Crude cell lysates from both strains were collected at the indicated time points and examined by immunoblot. In wild type cells, Fox3 levels decreased as expected (Fig. 8A) . In contrast, the apg2∆ strain accumulated Fox3 indicating it was defective in peroxisome degradation.
Apg2 is Required for the Peroxisome Degradation
We also monitored peroxisome levels in vivo by following a fluorescent peroxisome reporter protein. Addition of the amino acids Serine-Lysine-Leucine (SKL) to the COOH terminus of GFP causes the fusion protein to be targeted to the peroxisome lumen. The plasmid expressing GFPSKL was transformed into wild type and apg2∆ strains. Following induction of peroxisomes in YTO medium, cells expressing GFPSKL were shifted to starvation conditions.
The cultures were examined at various time points and the level of peroxisomes determined by fluorescence microscopy as described in "Experimental Procedures." In wild type cells, the GFPSKL signal was dramatically reduced by 12 h in SD-N and almost completely eliminated by 26 h (Fig. 8B) . In contrast, in apg2∆ cells there was essentially no change in peroxisome levels again indicating a defect in peroxisome degradation (Fig. 8B) . Together, these data suggest that Apg2 in S. cerevisiae plays a similar role in peroxisome degradation to the Gsa11 protein (P.E.
Stromhaug and W.A. Dunn Jr., manuscript in preparation) of P. pastoris.
DISCUSSION
Apg2 is Required for the Formation/Completion of Cvt Vesicles and
Autophagosomes-Autophagy is the specialized degradation process that cells use to transport bulk cytoplasm to the compartmentalized hydrolase-containing organelle, the vacuole/lysosome.
From studies over the past few years, the topology of autophagy has been described in detail and a few of the molecular mechanisms have been uncovered (1, 2) . The membrane trafficking machinery used in autophagy is similar to that of the Cvt pathway that is used for the biosynthetic delivery of prAPI to the vacuole in S. cerevisiae (1) (2) (3) (4) . Both processes require the formation of a sequestering vesicle in the cytosol. At present, the origin of the sequestering membrane is still a mystery. The identified mechanism required for the completion of the sequestering vesicle includes a novel ubiquitin-like conjugation machinery composed of Apg5, 7, 10, 12 and 16, and a regulatory multi-protein complex(es) that includes Apg1, 13, and 17 as well as Cvt9 and Vac8 (13,14; reviewed in 2). However, our knowledge about the exact sequence of events required for the completion of the Cvt vesicle/autophagosome is still limited. Therefore, the identification of additional molecular components involved in these pathways will further our understanding about the molecular details of the vesicle formation process. In this study, we characterized Apg2 as a new protein component in the Cvt and autophagy pathways. Taking advantage of the established model for the Cvt pathway, we assessed the role of Apg2 through biochemical analyses. Examining the apg2∆ strain, we found that prAPI accumulated in a protease-accessible form, suggesting that the sequestration step for the Cvt complex was not completed ( Fig. 2A) . Furthermore, a membrane-associated form of prAPI was detected in the float fraction through a Ficoll gradient (Fig. 2B) . Taken together, these findings implicate a direct role for Apg2 in the completion of the Cvt vesicle/autophagosome.
To survive starvation conditions, the vacuole/lysosome mediates the turnover and recycling of non-essential intracellular material for re-use in critical biosynthetic reactions through the autophagy pathway. Accordingly, the level of vacuolar proteolysis increases dramatically under these conditions and accounts for more than 85% of the degradative capacity of the cell (31) . The degree of viability of apg mutants during starvation is not equal, suggesting that there may be differing requirements for various proteins in the progression of autophagy (32). For example, the apg1∆ strain shows a greater loss of viability than the aut7∆ strain during starvation. Thus it has been suggested that proteins involved at the nucleation/signaling step show a complete loss of viability within a few days in starvation conditions, because they could not bypass the induction of autophagy. In contrast, mutants that have defects in genes whose products are required for the autophagosome expansion step, such as aut7∆, retain partial viability (32). The apg2∆ strain exhibited a complete loss of viability quickly after a shift to starvation conditions (Fig. 1B) . This phenotype indicated an absolutely essential role for Apg2 in autophagy.
Apg2 is a Peripheral Membrane Protein that Localizes to the Apg9 Compartment-To
investigate the function of Apg2 in the Cvt and autophagy pathways, we raised specific antiserum against this protein. In this study, we have demonstrated that Apg2 accumulated in both a soluble and pelletable fraction (Fig. 4B) . Further examination of the pelletable pool of Apg2, suggested that it behaved as a peripheral membrane protein (Fig. 4C ). We constructed a GFPApg2 fusion protein to carry out an in vivo analysis of Apg2. Interestingly, GFPAg2
showed better complementation of the prAPI accumulation phenotype of the apg2∆ strain under starvation conditions than in nutrient-rich conditions even though the apg2∆ mutant alone did not show any change in complementation in SMD versus SD-N (data not shown). This result suggests that the induction of other components during starvation may compensate for the partial function of GFPApg2 seen in nutrient-rich growth conditions. Microscopy analysis of GFPApg2 indicated that the fusion protein had both a cytosolic and perivacuolar, punctate distribution (Fig. 5 ). The solubility of Apg2 and GFPApg2 during subcellular fractionation was salt-dependent.
In physiological salt buffers containing MgCl 2 , the majority of Apg2 was found in a pelletable fraction. We think that the dispersed in vivo staining pattern corresponding to cytosolic GFPApg2 may in part present membrane-associated protein that is not localized to the perivacuolar dot. This is in agreement with observations in the accompanying paper from Shintani et al. based on analysis of the mutant protein GFPApg2p G83E . This protein is still partially pelletable following subcellular fractionation even though it shows a dispersed distribution in vivo. The punctate staining pattern seen with GFPApg2 was more intense under starvation conditions (Fig. 5 ), but this was not accompanied by a substantial increase in the level of the Apg2 protein. Instead, we think this reflects a higher level of recruitment of GFPApg2 to the perivacuolar dot structure during autophagy.
Because the GFPApg2 visual pattern was similar to other proteins including the integral membrane protein Apg9, we decided to extend our analysis by examining the fluorescent staining pattern in an apg9∆ strain. We found that GFPApg2 displayed a completely cytosolic distribution in the apg9∆ mutant (Fig. 5) . The loss of the punctate dot was not due to degradation of GFPApg2, suggesting that the protein relocated from, or could not be recruited to, the perivacuolar structure. These data suggest that in wild type cells, Apg2 is localized to a compartment that contains Apg9. To examine this more carefully, we looked at the localization of native Apg2 using a density gradient approach. By examining the comparative localization of Apg2 with several endomembrane markers, including the vacuole, Golgi, ER and endosome, we conclude that Apg2 localized at a compartment largely distinct from these organelles. Our gradient data suggest that Apg2 is present at the membrane compartment that contains the essential autophagy component Apg9 (Fig. 6 ). Furthermore, a protein affinity analysis with protein A-tagged Apg9 pulled down Apg2, suggesting a direct or indirect physical interaction between the two proteins (Fig. 7B) . Our results concerning the localization of Apg2 are in agreement with those of Shintani et al., who carried out an independent analysis of this protein (see accompanying paper). They found that the punctate distribution of Apg2 was blocked in the apg9∆ strain as well as in strains having mutations in APG1, APG6 or APG14.
As mentioned previously, the membrane sequestration process requires conjugation machinery that covalently attaches Apg12 to Apg5 (17,20). The Apg12-Apg5 conjugates were able to form in the apg2∆ strain. The conjugation reaction as well as post-translational processing and lipidation are required for the membrane binding of Aut7 (21, 22) . The apg2∆ strain was not defective in the membrane association of Aut7 (data not shown). Therefore, we suggest that Apg2 does not have a role in the conjugation of Apg12 to Apg5 or in other reactions that are required for membrane recruitment of Aut7. The question of whether Apg2 belongs to part of the regulatory complex that comprises Apg1, Apg13, Cvt9, Vac8 and Apg17 remains to be elucidated.
The apg2∆ Strain is Defective in Peroxisome Degradation-The monitoring of Fox3
degradation provides a useful tool to identify molecular components that are required for peroxisome degradation. In this study, we explored the role of Apg2 in pexophagy by following the stability of Fox3 following a shift from peroxisome-inducing to peroxisome-degrading conditions. We found that the apg2∆ strain was defective in peroxisome degradation as measured by the inability to degrade Fox3 (Fig. 8A) . Similarly, we monitored peroxisome levels in vivo with a peroxisome-targeted GFPSKL fusion protein.
As with the Fox3 analysis, we found that loss of the GFPSKL signal was blocked in the apg2∆ strain (Fig. 8B) . Together, these results suggest that Apg2 is the functional homolog of Gsa11 in P. pastoris (P.E.
Stromhaug and W.A. Dunn Jr., manuscript in preparation). Although it has been shown previously that some components shared by the Cvt pathway and autophagy are also involved in pexophagy (11), little is known about how the sequestration of peroxisomes is achieved in S.
cerevisiae. In the macropexophagy model as seen during ethanol adaptation in P. pastoris (1), peroxisomes are sequestered within cytosolic vesicles, which is a similar process to that of the Cvt and autophagy pathways. Alternatively, the engulfment of peroxisomes might occur at the vacuole surface by micropexophagy as is seen in P. pastoris during glucose adaptation (33). In either case, in S. cerevisiae we speculate that Apg2 has a general role in the completion stage for these pathways, however, it will be interesting to determine which mechanism is utilized in this yeast. APG2 also has homologs in humans (FLJ10242, 24% identity) and Schizosaccharomyces pombe (Spbc31e1.01cp, 22% identity), although in both cases nothing is known about the protein's function. There are now several examples of homologs to the yeast APG genes that are required for autophagy in animal cells (34). Hence, we can predict that in future studies Apg2
will also be shown to be involved in this process in higher eukaryotes.
Characterization of proteins involved in the Cvt and autophagy pathways has been under way for several years. We know that the majority of Cvt/Apg gene products are involved in the sequestration step, yet the exact mechanism that results in the formation of double-membrane vesicles is still unknown. In this study, we identify Apg2 as a novel protein in the sequestration step for the Cvt, autophagy and pexophagy pathways. The donor membrane source for the Cvt vesicles and autophagosomes remains unclear. One candidate protein for a marker of the source membrane is the transmembrane protein Apg9 that is required for both the Cvt pathway and autophagy. The present study is also the first report of a protein that co-localizes at the putative donor membrane source for the Cvt vesicle/autophagosome that is marked by Apg9. Future studies will be aimed at an analysis of the Apg9 compartment as well as the mechanism by which Apg2 directly participates in the vesicle sequestration stage for the Cvt and autophagy pathways. Spheroplasts isolated from apg2∆, apg7∆, and ypt7∆ cells were osmotically lysed (T, total) and centrifuged at 13,000 × g to obtain low-speed supernatant (S) and pellet (P) fractions. The pellet fractions were subjected to protease treatment in the absence or presence of 0.2% Triton X-100 as described in "Experimental Procedures." B, Precursor API in the apg2∆ strain accumulated in a membrane-associated float fraction. Spheroplasts from the apg2∆ strain were osmotically lysed (T, total) and separated into supernatant (S) and pellet (P) fractions by centrifugation at 13,000 × g for 10 min. The pellet fraction was resuspended in 15% Ficoll-400 in the absence or presence of 0.2% Triton X-100, and overlaid with 13% and 2% Ficoll-400 in a step gradient.
The gradients were centrifuged at 13,000 × g for 10 min at room temperature. Three fractions were collected including float (F), non-float (NF) and pellet (P2) fractions as described in spheroplasted at mid-log phase and osmotically lysed as described in "Experimental Procedures" in PS200 buffer without or with 5mM MgCl 2 . The total cell lysate (T) was separated into lowspeed supernatant (S13) and pellet (P13) fractions by centrifugation at 13,000 × g. The S13
fraction was further separated by high-speed centrifugation at 100,000 × g for 30 min to generate high-speed supernatant (S100) and pellet (P100) fractions. (JKY007) strains transformed with a plasmid expressing GFPApg2, and the non-transformed apg9∆ and wild type (SEY6210) strains were grown in SMD or shifted to SD-N as described in part A. Protein extracts were prepared and resolved by SDS polyacrylamide gel electrophoresis.
GFPApg2 and Apg2 were detected by western blot using antiserum against Apg2. 
